USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY,申请号EP20090763590-传众专利搜索

发明名称	USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
摘要	<p>Provided is a method of selecting a patient diagnosed with HCC as a candidate for IFN-αtherapy, by detecting the level of microRNA-26 expression in a sample obtained from the patient.</p>
申请公布号	EP2307028(A4)	申请公布日期	2011.09.28
申请号	EP20090763590	申请日期	2009.06.11
申请人	THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASREPRESENTED BY THE SECRETARY OF THE DEPARTMENT OFHEALTH AND HUMAN SERVICES;THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION;FUDAN UNIVERSITY	发明人	WANG, XIN, W.;JI, JUNFANG;CROCE, CARLO, M.;SUN, HUI-CHUAN;TANG, ZHAO-YOU
分类号	A61K31/70;C12Q1/68	主分类号	A61K31/70
代理机构		代理人
主权项
地址